3750 — Cytori Cell Research Institute Balance Sheet
0.000.00%
- ¥6bn
- ¥8bn
- ¥2bn
Annual balance sheet for Cytori Cell Research Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,000 | 1,070 | 852 | 1,123 | 1,038 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 81.8 | 117 | 113 | 58.3 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,480 | 6,270 | 3,029 | 1,388 | 1,428 |
Net Property, Plant And Equipment | 7,662 | 7,467 | 12,041 | 11,727 | 4,218 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 15,483 | 14,924 | 16,007 | 14,092 | 5,816 |
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 813 | 735 | 995 | 1,174 | 536 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,670 | 11,379 | 12,294 | 11,439 | 3,026 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 3,813 | 3,545 | 3,713 | 2,653 | 2,791 |
Total Liabilities & Shareholders' Equity | 15,483 | 14,924 | 16,007 | 14,092 | 5,816 |
Total Common Shares Outstanding |